GE HealthCare has partnered with Heart Hospital of New Mexico at Lovelace Medical Center (HHNM) to install its Allia Image Guided System (IGS) Pulse Electrophysiology Lab at the latter’s location in the US.

The Allia IGS Pulse aims to enhance image quality significantly and streamline workflows for diagnosing and treating cardiovascular diseases (CVD).

The system received the US Food and Drug Administration (FDA) 510(k) clearance in October last year.

HHNM plans to integrate the Allia IGS Pulse system into its cardiac electrophysiology (EP) lab.

According to GE HealthCare, the integration will facilitate the planning, guidance, and monitoring of electrophysiological procedures. It will help in operations like cardiac ablations, cardiac catheterisations, transcatheter aortic valve replacements, balloon angioplasties, coronary angioplasties, and other related procedures.

HHNM CEO Brian Miller said: “It’s an honour to have the US’s first Allia IGS Pulse system at Heart Hospital of New Mexico.

“As New Mexico’s only hospital dedicated exclusively to care of the heart, we pride ourselves on providing innovative treatment options for our patients, keeping them close to home for care.”

HHNM clinicians now have access to an adaptable solution designed to meet a variety of clinical needs and procedures.

The Allia IGS Pulse system enhances clinician workflow and ensures imaging quality at optimised doses, ensuring clear visibility during complex cardiology interventions regardless of patient size.

GE HealthCare interventional general manager Arnaud Marie said: “GE HealthCare has had a long-standing relationship with Lovelace Health System and has witnessed its ongoing leadership in providing the best possible care to its patients.

“We are delighted to collaborate with them for the first U.S. installation of the Allia IGS Pulse System.

“This next step is a demonstration of our commitment to addressing today’s healthcare challenges, unlocking efficiencies, and most importantly, providing optimal experiences for patients and their providers.”

Recently, the health technology firm launched new tools like MINItrace Magni, Omni Legend 21 cm and a new deep learning reconstruction technology Clarify DL to improve personalised care.